About Medio

About Medio Labs

We're building 
the future of clinical diagnostic services.

Medio Labs is applying the very latest DNA engineering and sequencing technologies to revolutionize clinical diagnostic testing. The company's innovations are designed to radically expand access to the latest diagnostic technology with the goal of driving a wholesale shift from treating health crises after they occur, to regular advanced screening that prevents healthcare crises from occurring in the first place.


Year we were founded


Tests processed by Medio & reference lab partners

Our approach

Impact Oriented

We are a diverse team of creative innovators who revel in making science fiction into real working technology with global impact.

At Medio Labs, we are driving a revolution in healthcare designed to massively reduce the cost of state-of-the-art clinical diagnostic testing and expand global access to quality care.

The company is applying deep expertise in clinical diagnostic assay design that leverages the latest next-generation sequencing platforms along with molecular bar codes written in RNA and attached chemically to patient samples to increase the scale and reduce the cost of quantifying multiple pathogens in every individual patient sample.

The impact of being able to test for multiple diseases that might have any number of symptoms in common using Just One Test™ is profound. Testing costs are dramatically reduced, Turn-around times are accelerated even in pandemic surges. Time to validated course of treatment is reduced, and patient outcomes improved.

Our values


We work on real problems that demand clear self knowledge, a recognition of important global challenges, and the difficulty of creating meaningful solutions that will have impact at large scale. We hold ourselves and our peers accountable.


Complex global challenges demand complicated, multi-component and multi-approach solutions. So we emphasize diversity of thought, background, ethnicity, skills, and approach that make a whole team much more capable of generating transformative services than the cookie-cutter approaches accessible to more homogenous teams.


When solving global challenges, there is no time to rest easy and just do more of what caused many of our problems. We have high standards of performance and self-motivation to excel, and accomplish what other consider impossible.


We don't keep or horde knowledge for individual political power in the organization. We hold the company's collective mission as more important than individual advancement. We don't keep secrets or politics. We leave ego at the door, and work to make the best ideas happen wherever they arise. We share knowledge and training to help everyone excel, grow, and succeed.


There is never a dull moment or boring routine when working on global challenges. We work on problems that are so important and impactful that the reasons to get out of bed every morning are completely clear. We are working hard to improve healthcare for everyone in the world, and to offer even the poorest and most remote people access to care when before, they had none.


We started Brainworks, and developed the Medio service specifically in service of global challenges that have defied easy solutions for decades. Our goal, put simply, is to use powerful new technology to save and extend lives.

Medio Labs Leadership

Zvi Huber

Chief Executive Officer
Zvi is a co-founder and CEO of the company. Previously, he lead the company's operations and technology development activities. Zvi has a long history of advanced technology development and rapid scaling and distribution of wireless communications products and services. His experience spans global IoT services. As the President of Stellar Satellite Communications, and later as a Senior VP at Orbcomm where he was responsible for their terminal division, Zvi was instrumental in taking Orbcomm to NASDAQ. More recently, Zvi served as CTO of Sfara, an advanced automotive sensing platform built on consumer cellular phones. Prior to Sfara, Zvi served in senior operational positions and was the US Plant Manager at Lutron Electronics.

Dan Turner

VP of Sales & Marketing
Dan leads the company's sales and marketing divisions with a 30 year history of driving sales and marketing initiatives in advertising, technology and medical industries including WebMD, Medscape, Ignite Media Asia, and Simple Labs. Dan also designed and implemented the WebMd strategy to link patients conducting web research directly with medical professional that offered care for those very conditions. Prior, Dan worked at NASA on Atmospheric Ionizing Radiation (AIR) Analysis.

Shana McDevitt

Director, Clinical Genomics
Shana is the former Director of the Genomics Sequencing Facilities at U.C., Berkeley and the Director of Clinical Operations at the Innovative Genomics Institute where she ran all pandemic response related clinical operations for local first responders and the entire UC Berkeley system. Prior, Shana ran and developed PCR-based sequencing technologies at the Oakland Children's Hospital, and has across her scientific career designed and managed technological workflows for 100s of national and international scholars and companies, representing the scientific kitchen sink of genomics. She holds a Master's Degree in Biomedical Sciences and has instructed graduate courses in DNA sequencing.

Dr. Matthew Settles

Director of BioInformatics
Matt has established and led a series of state-of-the-art genomics and bioinformatics laboratories at Washington State University, Univeristy of Idaho, and the U.C. Davis Genome Center. With over 90 genomics publications, Matt is recognized world-wide as an expert in genomics whose bioinformatics training program at UC Davis drew over 300 participants annually. He also played a pivotal role in establishing and running UC Davis' COVID testing facility which had performed over 1 Million tests before shutting down at the end of 2022. Matt hold's a M.S. degree in Computer Science, and a Ph.D. in BioInformatics and Computational Biology from the U. of Idaho.

Medio Board of Directors

Dr. Geoffrey Ling

Independent Director

Zvi Huber

Chief Executive Officer

Damian Black


Ready to take health to the next level?